No one I know in the industry is hiding a cure from you. Trust me.No but I get the gist of what he’s saying.
He’s not wrong. Keep stringing them along. Treat em don’t cure em. Healthy , cured people don’t make any money.
No one I know in the industry is hiding a cure from you. Trust me.No but I get the gist of what he’s saying.
He’s not wrong. Keep stringing them along. Treat em don’t cure em. Healthy , cured people don’t make any money.
No. But the biologics we develop do grow neurons. We are in the process of outfitting a lab to make these biologics. We will also be applying for patents on these compounds.Have you heard anything on the next generation cellular freqs (6g) being used to treat alzheimers/dementia with the mill/tera radio waves to stimulate/ re-activate dormant or decayed brain functions?
Setting that aside, big pharma may indeed have a mercenary streak, but surprisingly enough, in my 30+ years of working for them, they are nearly universally aligned in their desire to find cures to diseases. And they’ve become pretty damn close in a bunch (cf, ulcers)You're going to find a cure for 50k huh? You really are an idiot.
You will never convince me they are not driven by profit margin. Sick people are cash cows. For all you medical professionals: how much nutritional and preventative training did you have in medical school? Guessing it wasn't much.Setting that aside, big pharma may indeed have a mercenary streak, but surprisingly enough, in my 30+ years of working for them, they are nearly universally aligned in their desire to find cures to diseases. And they’ve become pretty damn close in a bunch (cf, ulcers)
All of what you've said is 1000 percent correct. Fully agree. Fyi, we produce a variety of biologics....in Iowa 😉Setting that aside, big pharma may indeed have a mercenary streak, but surprisingly enough, in my 30+ years of working for them, they are nearly universally aligned in their desire to find cures to diseases. And they’ve become pretty damn close in a bunch (cf, ulcers)
Re the cost, my sense is that as the science has become more elegant (almost unbelievably so), the target populations have become smaller, ergo the high price per therapy. The real challenge will be whether the underlying “platforms” can support the development of enough products to amortize the underlying platform costs. And the jury’s still out on that it seems to me.
Biologics prices should be lower with biosimilars, but the pbms have found a ways to prevent that in the near term (eg, with hi/low list versions and private labels). It’ll be interesting whether the ftc’s antitrust case goes anywhere under Trump.
OP’s Mom kills her clit with her vibrator every night.
So you're saying that there's a huge contradiction between the profit motive and the healthcare industry??Let’s assume some Pharma company discovered a sure-fire cancer cure for a cost of $50,000. They’d stand to make a ton of money.
But not as much as they’d make keeping a cancer patient alive for 5-6 years on a $60,000/yr chemo/radiation protocol.
🤷♂️
Amazing how industry solved the mfg supply chain issue for biologics. Years ago worked on a project for centocor and we were giving a friday pm update to the president. A guy came in and whispered In his ear, and he looked at us and said “we’re out of product”. I was like, that’s terrible do you have to go? He said, nope, happens every Friday about this time.All of what you've said is 1000 percent correct. Fully agree. Fyi, we produce a variety of biologics....in Iowa 😉
Very cool. If you have any sales gals or guys looking for a job, please let me know.Amazing how industry solved the mfg supply chain issue for biologics. Years ago worked on a project for centocor and we were giving a friday pm update to the president. A guy came in and whispered In his ear, and he looked at us and said “we’re out of product”. I was like, that’s terrible do you have to go? He said, nope, happens every Friday about this time.
It’s funny looking back, hadn’t thought of this before, but I’ve been pretty involved with a hell of a lot of launch and commercialization stuff on some the big early ones - remicade, procrit, enbrel, humira …